Skip to main navigation Skip to search Skip to main content

Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer

  • Natsuko Onishi
  • , Meredith Sadinski
  • , Mary C. Hughes
  • , Eun Sook Ko
  • , Peter Gibbs
  • , Katherine M. Gallagher
  • , Maggie M. Fung
  • , Theodore J. Hunt
  • , Danny F. Martinez
  • , Amita Shukla-Dave
  • , Elizabeth A. Morris
  • , Elizabeth J. Sutton
  • Memorial Sloan-Kettering Cancer Center
  • GE Healthcare United States

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Ultrafast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)-derived kinetic parameters have demonstrated at least equivalent accuracy to standard DCE-MRI in differentiating malignant from benign breast lesions. However, it is unclear if they have any efficacy as prognostic imaging markers. The aim of this study was to investigate the relationship between ultrafast DCE-MRI-derived kinetic parameters and breast cancer characteristics. Methods: Consecutive breast MRI examinations between February 2017 and January 2018 were retrospectively reviewed to determine those examinations that meet the following inclusion criteria: (1) BI-RADS 4-6 MRI performed on a 3T scanner with a 16-channel breast coil and (2) a hybrid clinical protocol with 15 phases of ultrafast DCE-MRI (temporal resolution of 2.7-4.6 s) followed by early and delayed phases of standard DCE-MRI. The study included 125 examinations with 142 biopsy-proven breast cancer lesions. Ultrafast DCE-MRI-derived kinetic parameters (maximum slope [MS] and bolus arrival time [BAT]) were calculated for the entire volume of each lesion. Comparisons of these parameters between different cancer characteristics were made using generalized estimating equations, accounting for the presence of multiple lesions per patient. All comparisons were exploratory and adjustment for multiple comparisons was not performed; P values < 0.05 were considered statistically significant. Results: Significantly larger MS and shorter BAT were observed for invasive carcinoma than ductal carcinoma in situ (DCIS) (P < 0.001 and P = 0.008, respectively). Significantly shorter BAT was observed for invasive carcinomas with more aggressive characteristics than those with less aggressive characteristics: grade 3 vs. grades 1-2 (P = 0.025), invasive ductal carcinoma vs. invasive lobular carcinoma (P = 0.002), and triple negative or HER2 type vs. luminal type (P < 0.001). Conclusions: Ultrafast DCE-MRI-derived parameters showed a strong relationship with some breast cancer characteristics, especially histopathology and molecular subtype.

Original languageEnglish
Article number02001292
JournalBreast Cancer Research
Volume22
Issue number1
DOIs
StatePublished - 28 May 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bolus arrival time
  • Breast carcinoma
  • Ductal carcinoma in situ
  • Invasive lobular carcinoma
  • Maximum slope
  • Molecular subtype
  • Ultrafast dynamic contrast-enhanced magnetic resonance imaging

Fingerprint

Dive into the research topics of 'Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer'. Together they form a unique fingerprint.

Cite this